How many insider trades does FilingIQ track for MRVI?

FilingIQ tracks 191 Form 4 insider transactions for MRVI (MARAVAI LIFESCIENCES HOLDINGS, INC.), covering filings from Nov 19, 2020 onwards. 2 of those were filed in the last 90 days.

Are MRVI insiders net buyers or net sellers?

Across the full Form 4 history for MRVI, 15 transactions (8%) were open-market purchases and 2 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does MRVI insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is MRVI in?

MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.15B.

MRVI insider trading

NasdaqGS Healthcare

MARAVAI LIFESCIENCES HOLDINGS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

191

Last 90 days

Buys / sells

8% / 1%

Market cap

$1.15B

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples. The CYGNUS segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products. It serves biopharmaceutical companies, and emerging biopharmaceutical and life sciences research companies; and academic research institutions and diagnostics companies. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.

Company website: www.maravai.com

MRVI insider activity at a glance

FilingIQ has scored 191 insider transactions for MRVI since Nov 19, 2020. The most recent filing in our index is dated Mar 16, 2026.

Across the full history, 15 open-market purchases and 2 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MRVI insider trades is 53.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live MRVI trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding MRVI

MIRABELLA FINANCIAL SERVICES LLP

$10.76M · 0.9% of AUM

Frequently asked

How many insider trades does FilingIQ track for MRVI?: FilingIQ tracks 191 Form 4 insider transactions for MRVI (MARAVAI LIFESCIENCES HOLDINGS, INC.), covering filings from Nov 19, 2020 onwards. 2 of those were filed in the last 90 days.
Are MRVI insiders net buyers or net sellers?: Across the full Form 4 history for MRVI, 15 transactions (8%) were open-market purchases and 2 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MRVI insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MRVI in?: MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.15B.

Methodology & sources

Every MRVI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.